Professor Tricia Naicker – South African Chemist Turns Antimicrobial Resistance Crisis into Career-Defining Mission

When Professor Tricia Naicker accepted the Distinguished Young Woman Researcher award at the 23rd South African Women in Science Awards in Johannesburg, the recognition capped a trajectory that has quietly reshaped how African science approaches one of modern medicine’s most stubborn threats.

At 38, Naicker already holds the distinction of being one of South Africa’s youngest full professors in Synthetic Chemistry, a position she earned at the University of KwaZulu-Natal (UKZN) where she directs the Catalysis and Peptide Research Unit. But titles matter less to her than the molecules her team designs — compounds engineered to outmaneuver bacteria that have evolved to defeat our most reliable antibiotics.

A Multidisciplinary Assault on Resistance

Antimicrobial resistance (AMR) kills an estimated 1.27 million people directly each year, with sub-Saharan Africa bearing a disproportionate burden. Naicker’s response has been to dissolve the boundaries between disciplines. Her unit brings synthetic chemists, microbiologists, and biochemists into the same laboratory, an approach that has yielded novel metallo-β-lactamase inhibitors — molecules that disable the bacterial enzymes responsible for neutralizing carbapenems, the antibiotics of last resort.

Several of these compounds have advanced to Phase 1 clinical trials, a rare milestone for research originating entirely from an African institution. The work also extends to radiopharmaceuticals and hybrid imaging agents, tools that could improve both diagnosis and targeted treatment of infectious diseases.

Building Capacity While Breaking Ground

“The science doesn’t happen in isolation,” Naicker said in a recent interview. “Every compound we synthesize represents dozens of decisions made by students and early-career researchers learning to think across disciplines.”

That philosophy is measurable. With an NRF C1 rating — the highest for established researchers — she has authored more than 130 peer-reviewed publications, secured a patent, and contributed three book chapters. But she counts the 35-plus PhD and master’s students she has supervised as her most enduring output. Many now lead research groups across Africa and beyond.

Her leadership extends beyond the lab. As outgoing Chair of the South African Chapter of the Organization for Women in Science for the Developing World (OWSD), and a member of both the South African Young Academy of Science and the African Academy of Sciences, Naicker has worked to expand the pipeline of women entering STEM fields. She serves as Editor-in-Chief of the South African Journal of Chemistry, using the platform to elevate African research visibility in global citation indexes.

A Model for Locally Driven Innovation

The SAWiSA award, presented by the Department of Science, Technology, and Innovation during Women’s Month, recognizes more than individual achievement. It signals a shift: African institutions are no longer merely adopting solutions developed elsewhere but are generating their own.

Naicker’s career illustrates what becomes possible when research funding, mentorship structures, and institutional support align. Her earlier accolades — the South African Chemical Institute Raikes Medal, the NRF Research Excellence Award for Early Career Researchers, the UKZN Vice-Chancellor’s Research Award, and the international John C. Warner Early Career Researcher Prize — trace a consistent pattern of recognition for work that is both scientifically rigorous and locally grounded.

As the World Health Organization warns that AMR could push 28 million people into extreme poverty by 2050, the compounds emerging from Naicker’s unit represent more than academic milestones. They are proof that the frontlines of drug discovery can be — and increasingly are — African.